Pharmafile Logo

Innovative Trials named Best global Patient Recruitment Company of 2021

Innovative Trials, has been named Best Global Patient Recruitment Company by the Healthcare & Pharmaceutical Awards 2021.

- PMLiVE

Innovative Trials, has been named Best Global Patient Recruitment Company by the Healthcare & Pharmaceutical Awards 2021. The awards, organised by Global Health & Pharma and now in their sixth year, aim to recognise ‘innovation, determination and outstanding levels of care demonstrated by those who place our wellbeing at the forefront of their practice’.

Founded in 2010, Innovative Trials is a UK-based company that works with some of the biggest pharmaceutical companies and Clinical Research Organisations (CROs) globally to help them reach their patient recruitment targets for trials, keep patients engaged and avoid costly delays in bringing effective new treatments to market. With a mission to accelerate recruitment to help bring treatments to patients sooner, the company has so far:

● worked on nearly 200 clinical trials
● recruited around 40,000 people into clinical trials
● played a part in six new treatments being approved for patients across the world.

In 2020, Innovative Trials also launched a campaign alongside two other organisations to ensure patients from under-represented ethnic groups are fairly represented in UK clinical and health research.

Kate Shaw, founder and CEO of Innovative Trials, said: “We are thrilled to receive such a ringing endorsement of our work, which is entirely due to the dedication of every single member of the team. At the heart of what we do is the drive to get life-changing medicines to patients more quickly; any delays to the clinical trial process inevitably means delays in getting potentially effective treatments to those who need them most. Indeed, one of our areas of expertise lies in supporting trials in danger of failing due to lack of participants. We work closely with sites and local communities to develop tailored strategies to engage, recruit and retain patients to ensure the trial can continue. It is one of the reasons our clients come back to us again and again.”

The Healthcare & Pharmaceutical Award is the second accolade to be given to Innovative Trials this year. The company was presented with a Queen’s Award for Enterprise in International Trade in June for its work to help bring new medicines to market.

For more information about Innovative Trials, visit www.innovativetrials.com

This content was provided by Innovative Trials

Company Details

 Latest Content from  Innovative Trials 

Retention Patch Program

A partnership between Innovative Trials and the non-profit Oliver Patch Project to boost retention in pediatric studies

Innovative Trials recognised at the PMEA Awards 2023 Gala Dinner

Global patient recruitment Innovative Trials took part of the PMEA Awards gala dinner alongside the best players in the pharmaceutical industry.

Innovative Trials launches the Retention Patch Program

Innovative Trials has unveiled a new partnership with the non-profit Oliver Patch Project to boost retention in pediatric studies.

Innovative Trials at the 2023 Lloyds Bank British Business Excellence Awards

Innovative Trials achievements recognized at the Lloyds Bank British Business Excellence Awards

Innovative Trials has been shortlisted in the PMEA Awards

Innovative Trials finalist in the Support Agency of the Year at the annual PMEA industry awards.

A New Era in Patient Recruitment & Retention

Innovative Trials launches ‘first of its kind’ service to boost clinical trial patient recruitment and retention .

Navigator - Revolutionize your patient recruitment and retention

Welcome to the new era in patient recruitment and retention

Innovative Trials partner with Great Ormond Street Hospital Children’s Charity

The patient recruitment company has chosen their UK charity partner for 2022/2023